June 12, 2018
Alvogen, Pfenex in a US marketed osteoporosis drug commercialization deal
Alvogen and Pfenex have signed a deal which grants Alvogen exclusive rights to commercialize Pfenex’s lead drug candidate, PF708, a…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Alvogen
December 12, 2016
Alvogen’s flu capsules alternative for Tamiflu
Alvogen on Monday launched the first flu capsules, generic equivalent to Roche’s Tamiflu (oseltamivir phosphate) capsules in the United States.
December 14, 2015
Alvogen to market Natco’s generic Tamiflu capsules until 2017
Alvogen to market Natco’s generic Tamiflu capsules until 2017.